PLASMA TAU LEVELS IN ALZHEIMER’S DISEASE
MARCH 28, 2013
Alzheimer’s Research & Therapy
Henrik Zetterberg, David Wilson, Ulf Andreasson, Lennart Minthon, Kaj Blennow, Jeffrey Randall and Oskar Hansson
Efforts to find reliable blood biomarkers for Alzheimer’s disease (AD) in a highly warranted clinical laboratory test have met with little success. There is no clear change in plasma ß-amyloid in AD, and assays for the axonal injury marker tau have been hampered by a lack of analytical sensitivity for accurate measurement in blood samples. Here, the results of a novel ultra-sensitive assay for tau in peripheral blood are reported. Publication: Alzheimer’s Research & Therapy 2013, 5:9.
Publication: Alzheimer’s Research & Therapy 2013, 5:9.
Share this page